rts logo

Biolase Inc (BIOL): These Numbers Show Where NASDAQ:BIOL Stock Is Going Next

Biolase Inc (NASDAQ: BIOL) is -82.78% lower on its value in year-to-date trading and has touched a low of $0.13 and a high of $47.10 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BIOL stock was last observed hovering at around $0.19 in the last trading session, with the day’s loss setting it 0.0%.

Currently trading at $0.19, the stock is 28.74% and -45.97% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.85 million and changing 1.79% at the moment leaves the stock -93.01% off its SMA200. BIOL registered -99.41% loss for a year compared to 6-month loss of -89.27%. The firm has a 50-day simple moving average (SMA 50) of $0.36 and a 200-day simple moving average (SMA200) of -$1.14.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 40.00% gain in the last 1 month and extending the period to 3 months gives it a -84.03%, and is 7.75% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.63% over the week and 12.96% over the month.

Biolase Inc (BIOL) has around 157 employees, a market worth around $6.28M and $49.16M in sales. Profit margin for the company is -76.52%. Distance from 52-week low is 54.44% and -99.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-259.26%).

Biolase Inc quarterly earnings per share for the current quarter are estimated at -$0.17 with sales reaching $10.14M over the same period.The EPS is expected to grow by 98.91% this year, but quarterly earnings will post 5.30% year-over-year. Quarterly sales are estimated to shrink -3.10% in year-over-year returns.

Biolase Inc (BIOL) Top Institutional Holders

18 institutions hold shares in Biolase Inc (BIOL), with institutional investors hold 8.27% of the company’s shares. The shares outstanding are 32.52M, and float is at 30.69M with Short Float at 0.94%. Institutions hold 8.24% of the Float.

The top institutional shareholder in the company is Walleye Capital LLC with over 14205.0 shares valued at $0.1 million. The investor’s holdings represent 1.36% of the BIOL Shares outstanding. As of Sep 29, 2023, the second largest holder is Zhang Financial LLC with 12078.0 shares valued at $22465.0 to account for 1.16% of the shares outstanding. The other top investors are Acadian Asset Management. LLC which holds 9617.0 shares representing 0.92% and valued at over $67992.0, while Avantax Planning Partners, Inc. holds 0.52% of the shares totaling 5441.0 with a market value of $38467.0.

Related Posts